Relay Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Relay Therapeutics (Nasdaq: RLAY) will present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 4:30 p.m. ET. The presentation will be available via a live webcast on Relay’s website, with an archived replay accessible for 30 days post-event. The company focuses on innovative drug discovery using its Dynamo platform, enhancing small molecule therapies targeting oncology. Relay Therapeutics aims to revolutionize the approach to previously challenging protein targets by utilizing advanced experimental and computational techniques.

CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 4:30 p.m. ET. The presentation will be webcast live and may be accessed from the Investor page of Relay’s website under Events and Presentations. An archived replay of the webcast will be available for at least 30 days following the presentation.

About Relay Therapeutics

Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, Relay Therapeutics aims to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The Company’s Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Pete Rahmer, Head of Investor Relations and Communications
617-322-0715
prahmer@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com

FAQ

When is Relay Therapeutics presenting at the J.P. Morgan Healthcare Conference?

Relay Therapeutics is set to present on January 12, 2021, at 4:30 p.m. ET.

How can I access Relay Therapeutics' presentation at the conference?

The presentation will be webcast live on Relay’s Investor page and available for 30 days afterward.

What is the primary focus of Relay Therapeutics?

Relay Therapeutics focuses on transforming drug discovery, particularly in targeted oncology, using its Dynamo platform.

What does the Dynamo platform do for Relay Therapeutics?

The Dynamo platform integrates experimental and computational methods to better understand protein structure and motion for drug discovery.

What is the stock symbol for Relay Therapeutics?

The stock symbol for Relay Therapeutics is RLAY.